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The many pitfalls in the accurate diagnosis of 
dementias are well documented.  While de-
finitive diagnosis remains the goal, the limits 
of clinicopathologic knowledge and current 
technology oftentimes preclude firm deci-
sions on a specific diagnosis, treatment and 
plans.  This is particularly pertinent in those 
cases where the lines between neurology and 
psychiatry become somewhat blurred.  In this 
report, I present the case of a patient with 
probable catatonic depression masquerading 
initially as frontotemporal dementia.  Includ-
ed is a brief discussion outlining our current 
knowledge about catatonia: its pertinent 
signs and symptoms for accurate diagnosis, 
its possible pathophysiologic mechanisms, 
and its relationship to dementia. 
 
Case Report 
 
The patient is a 56 year old right-handed 
gentleman who worked for several years in a 
supervisory role with the city department of 
public works and presented to our inpatient 
psychiatry unit for one month of worsening 
depression.  Neurovegetative symptoms in-
cluded insomnia, poor appetite and difficulty 
concentrating.  There was a potential precipi-
tating event as the patient’s mother had re- 
 
 
cently passed away about two months prior 
to admission. 
 
With the exception of one prior psychiatric 
admission about 20 years earlier, also for 
worsening depression in the context of a 
family issue, the patient had never consist-
ently required psychiatric attention.  About 
two years prior to this admission he had seen 
an outpatient psychiatrist for a couple of 
months secondary to anxiety and panic 
symptoms and was started on an SSRI and a 
benzodiazepine.  At the time of admission 
his only medications were HCTZ/
Triamterene for hypertension and Lumigan 
drops for glaucoma.  He had been off of all 
neuropsychiatric medications for at least one 
year.  His family history was only notable for 
question of late-onset dementia in the pa-
tient’s mother. 
 
The neurology service came to be involved 
with this patient after the admitting examina-
tion by the psychiatry resident noted subtle 
perseveration on testing of extraocular move-
ments, brisk reflexes and difficulty changing 
set despite a MMSE of 30/30.  An initial 
neurology consultation yielded a diagnosis of 
Cognitive Symptoms Due to Depression and 
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directly admitted to the inpatient neurology 
service for a rapidly progressive dementia 
workup.  Of significance, the patient’s MRI 
showed minimal nonspecific white matter 
changes but no atrophy (Figure 1) and the 
laboratory findings were not suggestive of 
any underlying neurologic etiology 
(summarized in Table 1).  An EEG in both 
the awake and asleep states was also normal. 
 
Over the course of the next four months the 
patient continued to decline, his verbal out-
put decreased and there were few spontane-
ous movements.  The patient was no longer 
getting out of bed to toilet himself, and he 
would not voluntarily eat even if the food 
was delivered to him.  Though there was no 
formal disagreement, the psychiatry service 
suspected a dementia diagnosis and the neu-
rology service tended toward a psychiatric 
etiology.  Eventually a trial of ECT was or-
dered but was unfortunately suspended early 
secondary to presumed increased confusion 
in the setting of a urinary tract infection. 
Soon thereafter the patient was sent for a se-
cond opinion at another large academic med-
ical center and returned to our outpatient  
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the brisk reflexes were explained by cervical 
pathology on MRI.  The inpatient psychiatry 
team resumed the patient’s SSRI and added 
an atypical antipsychotic to the regimen and 
after two weeks the patient was discharged to 
his home. 
 
After continued deterioration despite compli-
ance with medications the patient returned to 
the psychiatric emergency room a couple of 
months later.  Again he was admitted to the 
inpatient psychiatry unit and trials of new 
SSRI’s and atypical antipsychotic produced 
little clinical response.  Shortly after dis-
charge from the psychiatry service he was 
seen in the outpatient neurology clinic for 
follow-up of the original consultation. 
 
By this time the patient demonstrated mini-
mal verbal output, most responses being a 
rather stereotypic and hesitant “I don’t 
know” to all variety of questions.  His family 
noted  significant balance problems and he 
had fallen several times at home.  In addition 
to mild rigidity and a grasp reflex, the patient 
was also noted to have startle myoclonus on 
examination.  Subsequently the patient was  
 
 
Figure 1: Left image dated April 2006.  Right image dated September 2007. 
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clinic one month later with the opinion of 
likely frontotemporal dementia.  A decision 
had been made at the other institution to de-
fer further ECT treatments, and the family 
was advised to explore nursing home place-
ment options.  A PET scan at the other insti-
tution had apparently demonstrated fronto-
temporal hypometabolism, which along with 
the clinical evaluation had precipitated the 
above diagnosis. 
 
Approximately six months after the first psy-
chiatric hospitalization the patient returned to 
the inpatient neurology service.  On the se-
cond evening of admission the patient rather 
suddenly and unexpectedly shifted from his 
longstanding stuporous state to a verbally 
and physically aggressive appearance.  Intra-
muscular lorazepam was prescribed and 
within minutes the patient not only calmed 
down but voluntarily proceeded to get out of 
bed and go to the restroom.  Later that even-
ing he seemed to enjoy his dinner and con-
versed with family for the first time in 
months.  A standing dose of lorazepam was 
initiated, and a previously suggested diagno-
sis of a catatonic-like, rather than frontotem-
poral-like, state was supported. 
 
It is now two and a half years since the pa- 
 
tient’s initial presentation on the psychiatric 
unit.  His current medications include me-
mantine, topiramate and citalopram.  For a 
short period of time the patient also required 
olanzepine secondary to paranoid thoughts 
about leaving his home; but this medication, 
along with maintenance lorazepam, has been 
successfully discontinued over the past sev-
eral months.  Though he has been unable to 
return to his previous work, his sense of hu-
mor has returned, his abnormal gait has re-
solved and his performance on formal neuro-
psychological testing has improved.  A re-
peat PET scan was obtained and was normal, 
likely indicating that his previous scan was 
secondary to severe refractory depression 
rather than frontotemporal dementia. 
 
Discussion 
 
This patient’s case illustrates many of the 
important teaching points when considering a 
diagnosis of catatonia.  Most experts agree 
that catatonia is severely under-diagnosed in 
the neuropsychiatric community.  Theories 
exist to explain this phenomenon, such as 
lack of teaching about catatonia in medical 
school, lack of agreed-upon classifications 
and guidelines for recognizing catatonia, and 
a general lack of understanding of the patho- 
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 Basic Metabolic Panel: normal 
 Complete Blood Count: normal 
 Liver Function Tests: normal 
 Fasting Lipid Profile: normal 
 Amylase/Lipase: normal 
 Porphyrins: normal 
 TSH: normal 
 B12: normal 
 Folate: normal 
 CSF: 0 WBC, 0 RBC 
 CSF: protein, glucose normal 
 CSF: oligoclonal bands absent 
 CSF: 14-3-3 negative 
 Drugs of Abuse Screen: negative 
 Sedimentation Rate: 45 (High, >20) 
 HbA1C: normal 
 Serum Protein Electrophoresis: normal 
 Anti-Ri/Ma/Ta/Yo/Hu: negative 
 VDRL/RPR: non-reactive 
 Lyme Serum & CSF: unremarkable 
 EBV CSF: negative 
 Parv B19: negative 
 VCA-IgM/IgG: negative 
 EBNA-IgG: negative 
 Admark Tau/ABeta42: unremarkable 
Table 1: Laboratory Summary 
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physiology behind the catatonic state.  In-
deed, there is no consensus in the literature 
regarding the phenomenology of catatonia 
(Table 2).  As a consequence of unclear 
guidelines, there becomes a relative dispro-
portionate reliance on the art and experience 
of medical decision-making by an individual 
physician.  Inexperienced physicians become 
reluctant and hesitate to make the diagnosis 
and treat the condition.  Catatonia is often-
times relegated to “diagnosis by exclusion” 
or simply completely avoided. 
 
Delaying the treatment of catatonia negative-
ly impacts patient care, as it significantly re-
duces the likelihood of traditional (ECT, ben-
zodiazepine) treatment response.1  Thus, de-
ferring treatment until tests return to rule out 
known dementias might be detrimental. In 
fact, catatonia and dementia are not mutually 
exclusive diagnoses.2  The three cardinal cat-
atonic features (little or no spontaneous 
movement, mutism, refusal to eat or drink) 
are hallmark features of advanced dementia.3 
Perhaps treating the catatonic component of 
a patient’s dementing condition may amelio-
rate a reversible or modifying factor.4  At  
 
least 50 neurologic conditions have been 
identified as direct causes of secondary cata-
tonia symptomatology. 5  Missing a catatonia 
treatment opportunity might greatly alter a 
patient’s level of functioning. 
 
Not surprisingly the theories about catatonia 
pathophysiology and known dementias over-
lap considerably.  Theories include deficits in 
cortical development, dopaminergic hypoac-
tivity, low GABA-A receptor binding, frontal 
anomalies, dysfunction of norepinephrine 
and serotonin transmission and of course glu-
tamatergic dysfunction.5,6  A recent article 
reviewed adjunctive glutamate antagonist 
therapies in the treatment of catatonia and 
noted possible response with medications 
such as amantadine, memantine and topir-
amate.6  On the other hand, modalities that 
are now viewed with suspicion in the de-
mented patient, such as benzodiazepines or 
even ECT, might be more welcomed with 
further study.  The literature regarding the 
possibility of lorazepam-responsive demen-
tias illustrates this trend.7  As awareness of 
the catatonic state and its many varieties of 
presentation increases, so too might the 
EXCITEMENT 
 
Hyperkinesis  
Stereotypies [repetitive/ritualistic movements,  
         postures or utterances] 
Mannerisms [gestures that become abnormal  
         with exaggeration] 
Euphoria  
Irritability  
Rigidity 
Autonomic Changes 
     Hypertension 
     Hyperpyrexia 
     Diaphoresis 
     Tachycardia 
     Tachypnea  
     Mydriasis  
STUPOR 
 
Motor Behaviors 
       Catalepsy 
              Rigidity 
              Waxy Flexibility [maintained immobile posture] 
       Posturing 
              Psychological Pillow [continued elevation of   
         head as if supported by a pillow] 
              Grimacing 
Negativism 
       Gegenhalten 
       Mutism 
       Ambitendency [tendency to act in opposite ways 
                      from expected] 
Automatic Behaviors 
       Obedience [tendency to follow commands even if  
             harmful to self] 
       Echolalia 
       Echopraxia 
 
Table 2: Phenomenology of Catatonia 
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available multidimensional forms of treat-
ment for both catatonia and dementia. 
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